Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 6, 2004, Pages 689-695

  Siproudhis, L ^a,b   Dinasquet, M ^a   Sebille V ^a   Reymann, J M ^a   Bellissant, E ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO;

ADULT; ANORECTAL PRESSURE; ANUS; ANUS SPHINCTER; ARTICLE; BAROSTAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM MOTILITY; SINGLE DRUG DOSE; VISUAL ANALOG SCALE; VOLUNTEER;

ADOLESCENT; ADULT; AMITRIPTYLINE; ANAL CANAL; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FLUOXETINE; GASTROINTESTINAL MOTILITY; HUMANS; MALE; MANOMETRY; PERCEPTION; VISCERA;

EID: 4644317194     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02151.x     Document Type: Article

References (21)

1. Mertz H, Fass R, Kodner A, et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 160-5.
2. Poitras P, Riberdy-Poitras M, Plourde V, et al. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci 2002; 47: 914-20.
3. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125: 19-31.
4. Coquoz D, Porchet HC, Dayer P. Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers. Clin Pharmacol Ther 1993; 54: 339-44.
5. Poulsen L, Arendt-Nielsen L, Brosen K, et al. The hypoalgesic effect of imipramine in different human experimental pain models. Pain 1995; 60: 287-93.
6. Peghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998; 42: 807-13.
7. Gorelick AB, Koshy SS, Hooper FG, et al. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol 1998; 275: G460-6.
8. Siproudhis L, Bellissant E, Juguet F, et al. Effects of cholinergic agents on anorectal physiology. Aliment Pharmacol Ther 1998; 12: 747-54.
9. Siproudhis L, Bellissant E, Juguet F, et al. Octreotide acts on anorectal physiology: a dynamic study in healthy subjects. Clin Pharmacol Ther 1998; 64: 424-32.
10. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992; 49: 205-19.
11. McQuay HJ, Carroll D, Glynn CJ. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993; 48: 281-5.
12. Rani PU, Naidu MU, Prasad VB, et al. An evaluation of antidepressants in rheumatic pain conditions. Anesth Analg 1996; 83: 371-5.
13. Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of flbromyalgia. Arthritis Rheum 1996; 39: 1852-9.
14. Burleigh DE. Ng-nitro-L-arginine reduces nonadrenergic, noncholinergic relaxations of human gut. Gastroenterology 1992; 102: 679-83.
15. Rattan S, Sarkar A, Chakder S. Nitric oxide pathway in rectoanal inhibitory reflex of opossum internal anal sphincter. Gastroenterology 1992; 103: 43-50.
16. Vila JM, Medina P, Segarra G, et al. Relaxant effects of antidepressants on human isolated mesenteric arteries. Br J Clin Pharmacol 1999; 48: 223-9.
17. Medina P, Segarra G, Ballester R, et al Effects of antidepressants in adrenergic neurotransmission of human vas deferens. Urology 2000; 55: 592-7.
18. Pacher P, Ungvari Z, Kecskemeti V, et al. Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity. Br J Pharmacol 1999; 127: 740-6.
19. Ungvari Z, Pacher P, Koller A. Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i. J Cardiovasc Pharmacol 2000; 35: 849-54.
20. Bhardwaj R, Vaizey CJ, Boulos PB, et al. Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures. Gut 2000; 46: 861-8.
21. Ribeiro-do-Valle LE, Metzler CW, Jacobs BL. Facilitation of masseter EMG and masseteric (jaw-closure) reflex by serotonin in behaving cats. Brain Res 1991; 550: 197-204.